Morning Seminar April 22, 2008

Pediatr Blood Cancer. 2008 May;50(5):970-5.
Risk Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
Choi LM, Rood B, Kamani N, La Fond D, Packer RJ, Santi MR, Macdonald TJ.

Morning Seminar April 17, 2008

Pediatr Blood Cancer. 2006 Feb;46(2):228-33.
Risk factors for diabetes insipidus in langerhans cell histiocytosis.
Grois N, Pötschger U, Prosch H, Minkov M, Arico M, Braier J, Henter JI, Janka-Schaub G, Ladisch S, Ritter J, Steiner M, Unger E, Gadner H; DALHX- and LCH I and II Study Committee.

Morning Seminar April 15, 2008

J Clin Oncol. 2007 Nov 20;25(33):5254-61.
Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood.
Mussolin L, Pillon M, Conter V, Piglione M, Lo Nigro L, Pierani P, Micalizzi C, Buffardi S, Basso G, Zanesco L, Rosolen A.

Morning Seminar April 10, 2008

J Clin Oncol. 2008 Mar 20;26(9):1504-10.
Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F.

Morning Seminar April 8, 2008

J Clin Oncol. 2006 Apr 20;24(12):1917-23.
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Jeha S, Gaynon PS, Razzouk BI, Franklin J, Kadota R, Shen V, Luchtman-Jones L, Rytting M, Bomgaars LR, Rheingold S, Ritchey K, Albano E, Arceci RJ, Goldman S, Griffin T, Altman A, Gordon B, Steinherz L, Weitman S, Steinherz P.